South Africa launched Lenacapavir, a biannual HIV prevention injection, hailed as a game-changer. However, U.S. aid cuts and high costs limit access. Generic versions expected by 2027 at $40 yearly could drastically cut infections if widely adopted.
South Africa Launches HIV Prevention Shot Amid Funding Crisis
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →